Celebrity Chef Michael Smith voices support for GMO foods
Thursday, August 10, 2017
PEI's own celebrity chef, Michael Smith has come out in support of genetically-modified food at a consultation about Canada's Food Policy. Smith joined federal Agriculture Minister Lawrence MacAulay at a consultation Wednesday in Charlottetown — the first of five public consultations being held across the country over the next two months. Read more from CBC News website here.
Sekisui completes renovation and announces expansion in PEI
Tuesday, July 11, 2017
Graham Coll is one of many highly specialized workers who have been drawn to Sekisui Diagnostics both for its fast-growing international reputation and for its Prince Edward Island location. The Ontario native moved to the Island in 2013 to join the bioscience company as a process development scientist, which has allowed him to put his master’s in biotechnology to good use. Today officials from Sekisui Diagnostics joined government representatives to cut the ribbon on a just-completed $6 million renovation and to announce another major expansion, both of which include funding from the provincial government. Read more.
PEI leaders selected for Atlantic Business Top 50 CEO Awards
Sunday, May 21, 2017
Congratulations to two members of PEI's Bioscience Cluster, selected in Atlantic Business Magazine’s Top 50 CEO Awards: Dr. Alaa S. Abd-El-Aziz, President & Vice Chancellor, University of Prince Edward Island and Peter Crooks, Executive Director, Canada’s Smartest Kitchen and Founder & CEO, Idea2Market Inc.
BioVectra to Open New Microbial Fermentation and Complex Chemistry Site in 2017
Thursday, May 18, 2017
BioVectra Inc., a Contract Development and Manufacturing Organization (CDMO) providing cGMP services to globally operated biotech and pharmaceutical companies has announced that its fourth cGMP facility will be fully operational by December 2017. The late-stage to commercial-scale microbial fermentation and complex chemistry facility is located in Windsor, Nova Scotia, with proximity and service to Northeast USA development entities. The new $30 million investment increases BioVectra’s total manufacturing capacity by 40 per cent.
Delivra Signs Exclusive Licensing Deal for development of natural and medicinal Hemp Products
Thursday, May 11, 2017
Delivra Corp. (TSX VENTURE: DVA) and ARA-Avanti Rx Analytics Inc. ("Avanti") has announced a strategic partnership to develop a unique suite of standardized natural and medicinal products for the medical pain-related research, development, and commercialization markets, using hemp. Read News Release here.

<< Prev. 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > >